EntroGen is honored to participate in the 15th World Clinical Biomarkers & Companion Diagnostics Summit in Boston, taking place September 22-25. Dr. Gary Potikyan, EntroGen’s Chief Science Officer, will be a featured speaker.
Dr. Potikyan will present “World-Wide Clinical Trial Ready Assays as Distributed Kits: A Manufacturer’s Perspective of a Strategic Partnership Model” as part of the conference’s track on assay development and clinical implementation.
His presentation will outline how EntroGen supports global clinical trials and CDx programs through:
-
Collaborative Protocol Design: Early-stage assay co-development tailored to each study’s biomarker strategy and regulatory roadmap
-
GMP-Grade CTA Supply: Manufacturing and global distribution of high-quality, trial-ready kits with consistent performance across sites
-
Seamless Commercial Scale-Up: Transitioning validated CTAs into FDA- and IVDR-cleared diagnostics with established regulatory and logistics infrastructure
This talk highlights EntroGen’s commitment to enabling precision medicine through flexible, high-performance molecular diagnostics—from trial planning to commercial launch.
Learn more about the conference and register at world-cdx.com.
Presentation Details:
Date: Tuesday 23rd September 2025
Time: 4:00 PM
Location: The Westin Boston Seaport District 425 Summer Street, Boston, MA 02210